PMS-RIVAROXABAN

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 48d8ea130c1b1012
Drug Approval Canada Name: PMS-RIVAROXABAN
Product Name: PMS-RIVAROXABAN
Status: Marketed
Status Date: 2023-11-01
Original Market Date: 2023-11-01
Din: 02512068
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 20:12.04.14
Atc Original: B01AF01 RIVAROXABAN
Atc Name: b 01 af 01
Aig Number: 0152487002
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

RIVAROXABAN

15 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

48d8ea130c1b1012

Type

Standard